Home › Funds › Atom Investors LP › RARE

Atom Investors LP position in RARE

ULTRAGENYX PHARMACEUTICAL IN · Health Care

Atom Investors LP reported holding 171,771 shares of RARE (ULTRAGENYX PHARMACEUTICAL IN) in its Q2 2026 13F filing — a position valued at US$5.7M, representing 0.51% of its reported portfolio and ranking #20 among its reported holdings. Atom Investors LP has disclosed RARE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

Latest position (Q2 2026)171.77K sh
Reported value held$5.74M
Portfolio Weight0.51%
First reportedQ1 2026
Last changeAdd
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How Atom Investors LP's RARE position evolved

Atom Investors LP first disclosed a stake in RARE in Q1 2026 at 93,622 shares (US$2.0M). The position peaked in Q2 2026 at 171,771 shares, worth US$5.7M. Across 2 filings, Atom Investors LP increased the stake 1 time(s), trimmed it 0 time(s) and left it unchanged 0 time(s). The most recent filing (Q2 2026) shows 171,771 shares valued at US$5.7M — an increase of 78,149 shares quarter over quarter.. Notable position changes include a 83% increase in Q2 2026 (shares fell 55% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q1 2026 93.62K $1.96M New
Q2 2026 171.77K $5.74M Add

Dots on the line are colored by change type; missing quarters mean no position was reported.

About RARE and 13F data

RARE (ULTRAGENYX PHARMACEUTICAL IN) is a Health Care company. 27 other funds we track also report a position in RARE — the largest reported positions include RTW INVESTMENTS, LP (US$260.3M), SANDS CAPITAL MANAGEMENT, LLC (US$105.5M), FRONTIER CAPITAL MANAGEMENT CO LLC (US$95.1M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding RARE

All RARE fund holders →

FAQ

How long has Atom Investors LP held RARE?

Atom Investors LP has disclosed RARE holdings in 2 of the last 2 reported quarters, going back to Q1 2026.

What is Atom Investors LP's current position in RARE?

As of Q2 2026, Atom Investors LP holds 171.77K shares of RARE (ULTRAGENYX PHARMACEUTICAL IN), valued at $5.74M, representing 0.51% of its reported portfolio and ranking #20.

Has Atom Investors LP been buying or selling RARE?

In the latest 13F filing (Q2 2026), Atom Investors LP increased its position in RARE. The position peaked in Q2 2026 at 171.77K shares.

Which other funds hold RARE?

Other major institutional holders of RARE include RTW INVESTMENTS, LP, SANDS CAPITAL MANAGEMENT, LLC, FRONTIER CAPITAL MANAGEMENT CO LLC, among 27 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.